IP Library Granted Patent US 11,726,095
Granted Patent B2
US 11,726,095 · App. 14/907,701 · Granted Aug 15, 2023

Conjugating molecules to particles

Inventors: Nobuyoshi Joe Maeji (Queensland, AU); Chang-Yi Huang (Queensland, AU)
Assignee: ANTEO TECHNOLOGIES PTY LTD
G01N33/587C07K1/13C07K17/14G01N33/54326G01N33/553
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,726,095
App. No.
14/907,701
Granted
Aug 15, 2023
Kind
B2
Abstract

This invention resides in using metal complex-activated particles to bind molecules, polymers and other particles to each other, so as to produce multifunctional conjugates having controlled ratios of two or more different molecules.

Claims (24)

1. A nanoparticle including:

a surface including ligands, wherein said ligands include an electron-donating group;

transition metal ions at least partially coating the surface; and

a first target molecule and a second target molecule, wherein the first and second target molecules are different to each other and are present on the nanoparticle in a predetermined ratio,

wherein the nanoparticle includes a substrate formed from one or more substrate molecules or atoms; and

wherein, through the transition metal ions, co-ordination bonds are formed between; (i) the ligands including the electron-donating group at the nanoparticle surface and the first target molecule; and (ii) the ligands including the electron-donating group at the nanoparticle surface and the second target molecule; thereby separately linking the first and second target molecules to the nanoparticle surface; and

the nanoparticle further including a ligand, wherein the ligand for the transition metal ions is selected from the group consisting of: ethylenediamine, tetramethylethylenediamine, iminodiacetic acid, nitrilotriacetic acid, triphenylphosphine, oxalic acid, 1,10-phenanthroline, 8-hydroxyquinoline, salicylic acid, chloride, acetate, bromide, nitrate, perchlorate, alum, sulphate and pyridine.

2. The nanoparticle of claim 1 , wherein the nanoparticle has a diameter of about 5 to about 200 nm.

3. The nanoparticle of claim 1 , wherein the transition metal ion is selected from aluminum, rhodium, platinum, scandium, titanium, vanadium, chromium, ruthenium, manganese, iron, cobalt, nickel, copper, molybdenum, zirconium and zinc.

4. The nanoparticle of claim 3 , wherein the transition metal ion is chromium.

5. The nanoparticle of claim 1 , wherein each of the first and second target molecules is selected independently from a protein, a polynucleotide, a carbohydrate, a lipid, a drug, a labelling agent, a synthetic polymer and a nanoparticle.

6. A composition including:

a nanoparticle including a substrate formed from one or more substrate molecules or atoms, wherein the surface of the nanoparticle includes ligands which include an electron-donating group;

a ligand having a group for forming a co-ordination bond with a transition metal ion; and

a transition metal ion for forming a co-ordination bond with the one or more substrate molecules or atoms; a first target molecule and a second target molecule, wherein the first and second target molecules are different to each other;

wherein, through the transition metal ions, co-ordination bonds are formed between: (i) the ligands including the electron-donating group at the nanoparticle surface and the first target molecule; and (ii) the ligands including the electron-donating group at the nanoparticle surface and the second target molecule; thereby separately linking the first and second target molecules to the nanoparticle surface; wherein the first and second target molecules are present on the nanoparticle in a predetermined ratio; and

wherein the ligand for the transition metal ions is selected from the group consisting of: ethylenediamine, tetramethylethylenediamine, iminodiacetic acid, nitrilotriacetic acid, triphenylphosphine, oxalic acid, 1,10-phenanthroline, 8-hydroxyquinoline, salicylic acid, chloride, acetate, bromide, nitrate, perchlorate, alum, sulphate and pyridine.

7. The composition of claim 6 , wherein the particle has a diameter of about 5 to about 200 nm.

8. The composition of claim 6 , wherein the ligand is ethylenediamine.

9. The composition of claim 6 , wherein the transition metal ion is selected from aluminum, rhodium, platinum, scandium, titanium, vanadium, chromium, ruthenium, manganese, iron, cobalt, nickel, copper, molybdenum, zirconium and zinc.

10. The composition of claim 9 , wherein the metal ion is chromium.

11. The composition of claim 6 , wherein the first and second target molecules are independently selected from a protein, a polynucleotide, a carbohydrate, a lipid, a drug, a labelling agent, a synthetic polymer and a nanoparticle.

12. The nanoparticle of claim 1 , wherein the substrate molecule is selected from a synthetic polymer, a metal or metalloid composite, a biological material, ceramic, glass and metal oxide.

13. The nanoparticle of claim 1 , wherein the substrate atom is selected from gold, silicon and carbon.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2016
From: MAEJI, NOBUYOSHI JOE; HUANG, CHANG-YI
To: BIO-LAYER PTY LTD
Reel/Frame 037809/0487 →
CHANGE OF NAME Recorded Feb 24, 2016
From: BIO-LAYER PTY LTD
To: ANTEO TECHNOLOGIES PTY LTD
Reel/Frame 037899/0526 →
Priority Claims (1)
AU 2013903093 · Aug 13, 2013 · national
Continuity (1)
Related Publication 20160178636A1 · Jun 23, 2016